ASD-NP6 is developing a novel formulation of intestinally absorbed oral alpha-cyclodextrin as a unique 'intermittent fasting mimetic'
(CoM pat. pend) to promote healthy aging
by

- Maintaining lysosomal function

- Restoring autophaging,
   (ie, reducing garbaging) and

- Reducing inflammaging.